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Background
The studies concerning prophylactic treatment in bipo-
lar disorder suggest it should be introduced after the
first manic episode [1]. Also early polytherapy is pro-
moted, mainly mood stabilizers and antipsychotics.
Antipsychotics are recommended in short-term use [2],
but they are also used after improvement. Typical anti-
psychotics are effective in monotherapy in 70% of
patients, like mood stabilizers.[3] The combination of
antipsychotics and mood stabilizers is superior to mono-
therapy in rapid control of agitation.
Materials and methods
We determined which drugs are chosen at Institute of
Psychiatry and Neurology for treating and preventing
manic episodes. 61 inpatients diagnosed with manic
episodes were evaluated.At discharge, 28% of patient
were ordered to take one drug. For 72% patients poly-
therapy was ordered.
Results
There was no difference in the number of disease or
manic phases between the group of patients with a
remission phase lasting for at least a year and less than
a year. Recurrence within one year after discharge was
twice as frequent in patients with polytherapy than with
monotherapy. During polytherapy the probability of
avoiding recurrnce was dropping quickly.No dependence
was observed between the number of recurrences at
patients with monotherapy or polytherapy and such
parameters as the number of manic episodes, the num-
ber of depression episodes or education.
Conclusions
In most inpatients polytherapy was applied. For the
maintenance phase of treatment the same drugs were
recommended as used for active treatment. The way of
treatment fully corresponds to bipolar disorder treat-
ment standards.
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